Efficacy of twice weekly treatment for tuberculosis given under direct observation in Africa

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 1, 1997, Pages 87-89

  Wilkinson, David ^a,b,e   Anderson, Elizabeth ^b   Davies, Geraint R ^b   Sturm, A Willem ^c   McAdam, Keith P W J ^d  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b Hlabisa Hospital   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e CERSA (Hlabisa)   (South Africa)

Author keywords

Chemotherapy; Ethambutol; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampicin; South Africa; Tuberculosis; Twice weekly treatment

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDY; SPUTUM CULTURE; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0031044908     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90407-7     Document Type: Article

References (11)

1. Chan, S. L. (1994). Chemotherapy of tuberculosis. In: Clinical Tuberculosis, Davies, P. D. O. (editor). London: Chapman and Hall, pp. 141-156.
2. China Tuberculosis Control Collaboration (1996). Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis. Lancet, 347, 358-362.
3. Cohn, D. L., Catlin, B. J., Peterson, K. L., Judson, F. N. & Sbarbaro, J. A. (1990). A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice weekly, directly observed and cost-effective regimen. Annals of Internal Medicine, 112, 407-415.
4. Davies, G. R.,Wilkinson, D. & Colvin, M. (1996). HIV and tuberculosis. South African Medical Journal, 86, 91.
5. Kassim, S., Sassan-Morokoro, M., Ackah, A., Abouya, L. Y., Digbeu, H., Yesso, G., Coulibaly, I. M., Coulibaly, D., Whitaker, P. J., Doorly, R., Vetter, K. M., Brattegaard, K., Gnaore, E., Greenberg, A. E., Wiktor, S. Z. & De Cock, K. M. (1995). Two-year follow-up of persons with HIV-1 and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS, 9, 1185-1191.
6. Perriens, J. H., St Louis, M. E., Mukadi, Y. B., Brown, C., Prignot, J., Pouthier, F., Porteals, F., Willame, J. C., Mandala, J. K., Kaboto, M., Ryder, R. W., Roscigno, G. & Piot, P. (1995). Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. New England Journal of Medicine, 332, 779-784.
7. Van Embden, J. D. A., Cave, M. D., Crawford, J. T., Dale, J. W., Eisenach, K. D., Gicquel, B., Herman, P. W. M., Martic, C., McAdam, R., Shinnick, T. M. & Small, P. M. (1993). Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendation for a standardised methodology. Journal of Clinical Microbiology, 31, 406-409.
8. WHO (1993). Treatment of Tuberculosis. Guidelines for National Programmes. Geneva: World Health Organization.
9. Wilkinson, D. (1994). High-compliance tuberculosis treatment programme in a rural community. Lancet, 343, 647-648.
10. Wilkinson, D. & Moore, D. J. (1996). HIV-related tuberculosis in South Africa: clinical features and outcome. South African Medical Journal, 86, 64-67.
11. Wilkinson, D., Davies, G. R. & Connolly, C. (1996). Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994. American Journal of Public Health, 86, 1094-1097.